SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community debates its long-term utility and potential for institutional adoption following recent stablecoin payroll integrations on the Stellar network. Investors are actively discussing the impact of finalized token unlocks, while opinions remain divided between those betting on major upcoming partnership announcements and others expressing skepticism toward price performance.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased market attention driven by high-profile research highlighting its post-quantum security features, fueling discussions about its long-term viability as an enterprise-grade Layer-1 blockchain. Community members are actively debating the potential impact of this technology on future institutional adoption, with sentiment shifting between speculative optimism regarding its undervalued market position and cautious monitoring of price volatility.

Maul Coin

Maul Coin is generating buzz among community members who are actively rallying to drive up its market cap through coordinated social media raids and promotional efforts. Investors are drawn to the project's grassroots origins, emphasizing the active involvement of the developer and a community-driven focus as they push for increased visibility and organic growth.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending following its strategic acquisition of StereoLabs, a move that establishes a unified sensing and perception platform for Physical AI by integrating digital lidar with stereo vision technology. The community is actively discussing how this expansion enhances Ouster's competitive edge in robotics and industrial markets while reinforcing its path to profitability ahead of upcoming earnings.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is gaining momentum as investors position themselves for the upcoming Dromos event, with the community closely tracking its role as the primary liquidity hub for the Base ecosystem. Sentiment remains anchored in the protocol's revenue-generating utility and the anticipation of broader market rotation into altcoins as traders monitor key technical resistance levels.

Mezo is the onchain Bitcoin banking platform owned by its users. Users can access self-service Bitcoin finance without interacting with loan officers, undergoing credit checks, or observing operational hours. It’s just you, your Bitcoin, and permissionless access to financial services 24/7.  Traditional banks profit from your deposits while charging you for access to your own money. Two-sided lending markets trap you with 8-9% variable rates that can spike unpredictably, especially in decentralized financial systems. Both systems put middlemen between you and your wealth.  Mezo eliminates them all, giving you the power to manage your finances intelligently on your own terms.  Deposit Bitcoin as collateral, mint MUSD (a dollar-pegged stablecoin), and use it however you need. Your Bitcoin stays yours while MUSD provides you with instant liquidity. Fixed rates start as low as 1% and stay fixed for the entire life of the loan.  This is self-service banking with complete autonomy. Unlike any traditional banking experience, there are no minimum payments, set repayment schedules, or penalties for early repayment. Close your position tomorrow or keep it open for years.  It’s your Bitcoin and your decision on what to do with it.

MEZO

Mezo is trending following its recent exchange listing and a strategic partnership with Aerodrome Finance aimed at strengthening Bitcoin-based DeFi utility. Community discourse is heavily focused on the token's infrastructure role, potential supply constraints, and its integration into the Bitcoin ecosystem for governance and staking.

TORM Plc engages in the business of transporting clean and dirty petroleum products. It operates under the Tanker and Marine Engineering segments. The Tanker segment focuses on the transportation of refined oil products such as gasoline, jet fuel, kerosene, and naphtha. The Marine Engineering segment includes developing and producing advanced and green marine equipment. The company was founded by Ditlev E. Torm and Christian Schmiegelow in 1889 and is headquartered in London, the United Kingdom.

Torm Plc - Ordinary Shares - Class A

Torm Plc (TRMD) is trending as investors debate the impact of escalating Middle East tensions and potential 'insurance cliffs' on global tanker rates, leading to intense discussion over whether the stock is a deep-value opportunity or a high-risk trap. While some community members point to rising freight rates and structural supply shortages as catalysts for a rebound, others are cautious due to volatile price action and ongoing rotation out of the shipping sector.

NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. Its product, IB-Stim, is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.

Neuraxis Inc

NeurAxis is gaining significant market attention following the FDA clearance for its IB-Stim device to treat functional abdominal pain in patients aged 8 to 21, marking a key milestone for its commercial rollout. While the community is actively debating the potential for a short squeeze and long-term revenue growth driven by new CPT coding and insurance coverage, discussions are also tempered by concerns over recent share offerings and stock price volatility.

QuickLogic Corp. operates as a semiconductor company, which designs, markets, and supports primarily Customer Specific Standard Products and secondarily, Field Programmable Gate Arrays, sensor software algorithms, software drivers, associated design software and programming hardware. It develops and markets low power customizable semiconductor and software algorithm solutions that enable customers to differentiate their products by adding new features, extending battery life, becoming more contextually aware and improving the visual experience with their mobile, consumer and enterprise products. The company was founded by John M. Birkner, Andrew K. Chan, and Hua-Thye Chua in 1988 and is headquartered in San Jose, CA.

Quicklogic Corp

QuickLogic is gaining significant traction within the aerospace and defense sectors, driven by its strategic positioning as the only provider of eFPGA IP optimized for Intel 18A technology. The community is actively monitoring the company's expanding contract backlog and its critical role in secure, domestic microelectronics production, which many investors view as a long-term catalyst for growth.

Sphere Entertainment Co. engages in the provision of live entertainment and media services. It operates through the following segments: Sphere and MSG Networks. The Sphere segment engages in deriving revenues primarily from ticket sales and other ticket-related revenues, venue license fees from third-party promoters, sponsorships, signage and Exosphere advertising, suite licenses and food, beverage, and merchandise sales. The MSG Networks segment engages in deriving revenues principally from distribution fees, as well as from the sale of advertising. The company was founded in 2010 and is headquartered in New York, NY.

Sphere Entertainment Co - Ordinary Shares - Class A

Sphere Entertainment Co

Sphere Entertainment is seeing significant market momentum following a series of successful high-profile residencies and positive analyst revisions, fueling community excitement around the company's long-term venue expansion strategy. Investors are actively debating the potential for long-term operational leverage, with many focusing on the venue's ability to maintain high utilization rates and drive revenue through its unique, immersive entertainment model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Innate Pharma to Participate in the Kempen Life Sciences Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced...

Innate Pharma Files Its 2025 Universal Registration Document (Document Denregistrement Universel) and 2025 Form 20-f Annual Report

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) today announced the filing of its 2025 Universal Registration Document (Document denregistrement...

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Sees Large Decline in Short Interest

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) saw a large decline in short interest in the month of March. As of March 13th, there was short interest totaling 76,183 shares, a...

Innate Pharma Q4 Earnings Call Highlights

Innate Pharma (NASDAQ:IPHA) outlined progress across its prioritized oncology pipeline and reviewed full-year 2025 financial results, emphasizing a streamlined strategy centered on three clinical...

Innate Pharma (NASDAQ:IPHA) Releases Earnings Results, Beats Expectations By $0.17 EPS

Innate Pharma (NASDAQ:IPHA - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.18) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.35) by $0.17. The business had revenue of $2.42 million during the quarter, compared to...

Innate Pharma Reports Full Year 2025 Financial Results and Business Update

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) today reported its business update and consolidated financial results for the year ending December 31...

Innate Pharma Announces Conference Call and Webcast for Full Year 2025 Financial Results

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), today announces that the Company will hold a conference call on Thursday, March 26, 2026 at 2 p.m. CET...

Innate Pharma (IPHA) Projected to Post Earnings on Thursday

Innate Pharma (NASDAQ:IPHA) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at...

Innate Pharma (IPHYF) Expected to Announce Quarterly Earnings on Thursday

Innate Pharma (OTCMKTS:IPHYF) will be releasing earnings before the market opens on Thursday, March 26. (View Earnings Report at...

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Short Interest Update

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) was the recipient of a significant decline in short interest in February. As of February 27th, there was short interest totaling...

Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Hervé Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié, and François Romagné on September 23, 1999 and is headquartered in Marseille, France.

Innate Pharma - ADR

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

IPHA
Innate Pharma

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest IPHA News

IPHAInnate Pharma